Cerebro-spinal fluid studies in alcoholics and violent offenders

References

• Potter JF, Bannan LT, Beevers DG. Alcohol and hypertension. Br J Addict 1984; 79: 365–372
   PubMedGoogle Scholar
• Borg S, Kvande H, Sedvall G. Central norepinephrine metabolism during alcohol intoxication in addicts and healthy volunteers. Science 1981; 213: 1135–1137
   PubMed Web of Science ®Google Scholar
• Hawley RJ, Major LF, Schulman EA, Lake CR. CSF levels of norepinephrine during alcohol withdrawal. Arch Neurol 1981; 38: 289–292
   PubMed Web of Science ®Google Scholar
• Hawley RJ, Major LF, Schulman EA, Linnoila M. Cerebrospinal fluid 3-methoxy-r-hydroxyphenylglycol and norepinephrine levels in alcohol withdrawal. Arch Gen Psychiatry 1985; 42: 1056–1062
   PubMed Web of Science ®Google Scholar
• Kopin IJ, Gordon EK, Jimerson DC, Polinsky RJ. Relation between plasma and cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylglycol. Science 1983; 219: 73–75
   PubMed Web of Science ®Google Scholar
• Nutt DJ, Glue PG, Molyneux SG, Clark E. Clonidine in alcohol withdrawal. Alcoholism (NY), in press
   Google Scholar
• Fujimoto A, Nagaop T, Ebara T, Sato M, Otsuki S. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state. Biol Psychiatry 1983; 18: 1141–1152
   PubMed Web of Science ®Google Scholar
• Borg S, Liljeberg P, Mossberg R. Clinical studies on central noradrenergic activity in alcohol abusing patients. Acta Psychiatr Scand (suppl) 1986; 327: 43–60
   Google Scholar
• Borg S, Kvande H, Mossberg R, Valverius P, Sedvall G. Central nervous system noradrenaline metabolism and alcohol consumption in man. Pharmacol Biochem Behav 1983, suppl 1: 375–378
   PubMedGoogle Scholar
• Hawley RJ, Major LF, Schulman EA, Trocha PJ, Takenaga JK, Catravas GN. Cerebrospinal fluid cyclic nucleotides and GABA do not change in alcohol withdrawal. Life Sci 1981; 28: 295–299
   PubMed Web of Science ®Google Scholar
• Asberg M, Traskman L, Thoren P. 5-HIAA in the cerebrospinal fluid — a biochemical suicide predictor?. Arch Gen Psychiatry 1976; 33: 1193–1197
   PubMed Web of Science ®Google Scholar
• Linnoila M, Virkkunen M, Scheinin M, Rimon R, Goodwin FK. Low cerebralspinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent offenders. Life Sci 1983; 33: 2609–2614
   PubMed Web of Science ®Google Scholar
• Virkkunen M, Nuutila A, Goodwin FK, Linnoila M. CSF monamine metabolites in male arsonists. Arch Gen Psychiatry 1987; 44: 241–247
   PubMed Web of Science ®Google Scholar
• Takahashi S, Yamane H, Kondo H, Tani N, Kato N. CSF monoamine metabolites in alcoholism; a comparative study with depression. Folia Psychiatr Neurol Jpn 1974; 28: 347–354
   PubMedGoogle Scholar
• Zarcone V, Barchas J, Hoddes E, Montplaisir J, Sack R, Wilson R. Experimental alcohol ingestion: sleep variables and metabolites of dopamine and serotonin in the cerebrospinal fluid. Adv Exp Med Biol 1981; 59: 89–101
   Google Scholar
• Ballenger JC, Goodwin FK, Major LF, Brown GL. Alcohol and central serotonin metabolism in man. Arch Gen Psychiatry 1979; 36: 224–227
   PubMed Web of Science ®Google Scholar
• Banki CM. Factors influencing monoamine metabolites and tryptophan in patients with alcohol dependence. J Neurol Transm 1981; 509: 89–101
   Google Scholar
• Borg S, Kvande H, Liljeberg P, Mossberg R, Valverius P. 5-Hydroxyindoleacetic acid in cerebrospinal fluid in alcoholic patients under different clinical conditions. Alcohol 1985; 2: 415–418
   PubMed Web of Science ®Google Scholar
• Cloninger C, Bohman M, Sigvardsson S. Inheritance of alcohol abuse: cross fostering analysis of adopted men. Arch Gen Psychiatry 1981; 38: 861–886
   PubMed Web of Science ®Google Scholar
• Nutt DJ, Glue PG. Monoamines and alcohol. Br J Addict 1986; 81: 327–338
   PubMedGoogle Scholar
• Orenberg EK, Zarcone VP, Renson JF, Barchas JD. The effects of ethanol ingestion on cyclic AMP homovanillic acid and 5-hydroxyindoleacetic acid in human cerebrospinal fluid. Life Sci(year?), 19: 1669–1672
   PubMed Web of Science ®Google Scholar
• Sjoqvist B, Borg S. Catecholeamines and their metabolites in cerebrospinal fluid of teetotallers and sober alcoholics. Drug Alcohol Depend 1984; 13: 389–394
   PubMedGoogle Scholar
• Major L, Ballenger J, Goodwin F, Brown G. Cerebrospinal fluid homovanillic acid in male alcoholics; effects of disulfiram. Biol Psychiatry 1977; 12: 635–642
   PubMed Web of Science ®Google Scholar
• Track NS, Carlen PL. Motilin and human pancreatic polypeptide measured in CSF from alcoholic and non-alcoholic neurological patients. Peptides 1986; 7: 1193–1195
   PubMed Web of Science ®Google Scholar
• Salvoldi, F, Mazzella, GL, Fanchinetti, F, et al. Beta-endorphin, beta-lipotropin and adrenocorticotropic hormone levels in cerebrospinal fluid and brain damage in chronic alcoholics. Eur Neurol 1983; 22: 265–271
   PubMed Web of Science ®Google Scholar
• Martin PR, Adinoff B, Weingartner H, Mukherjee AB, Eckardt MJ. Alcoholic organic brain disease: nosology and pathophysiologic mechanisms. Prog Neuro-psychopharmacol Biol Psychiatry 1986; 10: 147–164
   PubMed Web of Science ®Google Scholar